(1.20%) 5 070.55 points
(0.69%) 38 504 points
(1.59%) 15 697 points
(0.10%) $83.44
(1.16%) $1.833
(-0.25%) $2 336.30
(-0.21%) $27.31
(-0.20%) $921.00
(0.01%) $0.934
(0.02%) $10.91
(0.00%) $0.803
(0.00%) $93.19
@ $65.00
Issued: 23 Apr 2024 @ 15:39
Return: -0.91%
Previous signal: Apr 23 - 10:20
Previous signal:
Return: 1.31 %
Live Chart Being Loaded With Signals
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide...
Stats | |
---|---|
Today's Volume | 568 454 |
Average Volume | 924 333 |
Market Cap | 4.42B |
EPS | $0 ( 2024-02-22 ) |
Next earnings date | ( $1.550 ) 2024-05-02 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 13.85 |
ATR14 | $2.95 (4.57%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-17 | Blanchfield Paul | Sell | 455 | Common Stock |
2024-04-15 | Sabens Andrea | Sell | 341 | Common Stock |
2024-03-25 | Morgan Amanda Michelle | Sell | 0 | Common Stock |
2024-03-25 | Morgan Amanda Michelle | Sell | 10 310 | Stock Option (Right to Buy) |
2024-03-25 | Morgan Amanda Michelle | Sell | 5 432 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
16.29 |
Last 100 transactions |
Buy: 601 463 | Sell: 442 334 |
Volume Correlation
Lantheus Holdings Inc Correlation
10 Most Positive Correlations | |
---|---|
PDFS | 0.964 |
LMNR | 0.964 |
RAM | 0.957 |
AMPH | 0.957 |
SGEN | 0.956 |
OMAB | 0.948 |
GEOS | 0.947 |
ALTR | 0.943 |
ANSS | 0.942 |
NSIT | 0.941 |
10 Most Negative Correlations | |
---|---|
WTBA | -0.961 |
FGBI | -0.957 |
GNTY | -0.957 |
ALXO | -0.954 |
ALLK | -0.949 |
ACRX | -0.947 |
TNGX | -0.943 |
AROW | -0.941 |
MICS | -0.941 |
RDVT | -0.94 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Lantheus Holdings Inc Correlation - Currency/Commodity
Lantheus Holdings Inc Financials
Annual | 2023 |
Revenue: | $1.30B |
Gross Profit: | $709.54M (54.73 %) |
EPS: | $4.79 |
Q4 | 2023 |
Revenue: | $354.00M |
Gross Profit: | $229.87M (64.93 %) |
EPS: | $1.510 |
Q3 | 2023 |
Revenue: | $319.95M |
Gross Profit: | $199.95M (62.50 %) |
EPS: | $1.930 |
Q2 | 2023 |
Revenue: | $321.70M |
Gross Profit: | $202.65M (62.99 %) |
EPS: | $1.380 |
Financial Reports:
No articles found.
Lantheus Holdings Inc
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for nuclear medicine; Xenon-133 to assess pulmonary function; Neurolite to identify the area within the brain where blood flow has been blocked or reduced due to stroke; Cardiolite, an injectable Tc-99m-labeled imaging agent; Thallium-201 to detect cardiovascular disease; and Gallium-67 to detect various infections and cancerous tumors. The company also offers AZEDRA, a radiotherapeutic to treat adult and pediatric patients; Automated Bone Scan Index that calculates the disease burden of prostate cancer by quantifying the hotspots on bone scans; and Cobalt (Co 57), a non-pharmaceutical radiochemical; RELISTOR for opioid-induced constipation; and PYLARIFY for visualization of lymph nodes, bone, and soft tissue metastases to determine the presence or absence of recurrent and/or metastatic prostate cancer. It also develops flurpiridaz F 18 to assess blood flow to the heart; 1095, a PSMA-targeted iodine-131 labeled small molecule; LMI 1195 for neuroblastoma tumors in pediatric and adults; PYLARIFY AI, an AI-based medical device software to perform standardized quantitative assessment of PSMA PET/CT images in prostate cancer; and leronlimab, an investigational humanized monoclonal antibody. The company serves radio pharmacies, distributors, integrated delivery networks, hospitals, clinics, and group practices. It has strategic partnerships with NanoMab Technology Limited; Bausch Health Companies, Inc.; GE Healthcare Limited; Curium; Bayer AG; CytoDyn Inc.; ROTOP; FUJIFILM; Regeneron Pharmaceuticals, Inc.; and POINT Biopharma US Inc. The company was founded in 1956 and is headquartered in North Billerica, Massachusetts.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators